R. Ansorg

1.7k total citations
87 papers, 1.3k citations indexed

About

R. Ansorg is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, R. Ansorg has authored 87 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 22 papers in Molecular Biology and 18 papers in Epidemiology. Recurrent topics in R. Ansorg's work include Antifungal resistance and susceptibility (20 papers), Helicobacter pylori-related gastroenterology studies (15 papers) and Bacterial biofilms and quorum sensing (9 papers). R. Ansorg is often cited by papers focused on Antifungal resistance and susceptibility (20 papers), Helicobacter pylori-related gastroenterology studies (15 papers) and Bacterial biofilms and quorum sensing (9 papers). R. Ansorg collaborates with scholars based in Germany, Kenya and Switzerland. R. Ansorg's co-authors include Werner Fabry, P. O. Okemo, P.‐M. Rath, G. von Recklinghausen, E. N. Schmid, Peter‐Michael Rath, Karl‐Dieter Müller, W. Behrens‐Baumann, Ernst N. Schmid and F. Scheler and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and Journal of Ethnopharmacology.

In The Last Decade

R. Ansorg

85 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Ansorg Germany 18 377 336 300 241 233 87 1.3k
Paul F. Lehmann United States 27 995 2.6× 399 1.2× 877 2.9× 138 0.6× 188 0.8× 50 2.2k
Deepak Aggarwal India 19 394 1.0× 1.1k 3.4× 296 1.0× 186 0.8× 271 1.2× 83 2.3k
W. Fegeler Germany 19 969 2.6× 144 0.4× 747 2.5× 53 0.2× 157 0.7× 55 1.6k
T. V. Riley Australia 19 330 0.9× 245 0.7× 252 0.8× 54 0.2× 547 2.3× 37 1.3k
Bruna Facinelli Italy 24 656 1.7× 200 0.6× 527 1.8× 83 0.3× 506 2.2× 51 2.2k
Fumiaki Ikeda Japan 26 1.1k 2.9× 196 0.6× 881 2.9× 259 1.1× 83 0.4× 77 2.3k
Alicja Budak Poland 17 221 0.6× 65 0.2× 182 0.6× 217 0.9× 126 0.5× 42 723
Nicola Carlone Italy 15 171 0.5× 143 0.4× 203 0.7× 40 0.2× 210 0.9× 62 767
M. Cuenca-Estrella Spain 10 534 1.4× 119 0.4× 371 1.2× 34 0.1× 151 0.6× 14 877
Paola Molicotti Italy 26 609 1.6× 208 0.6× 598 2.0× 312 1.3× 317 1.4× 79 1.7k

Countries citing papers authored by R. Ansorg

Since Specialization
Citations

This map shows the geographic impact of R. Ansorg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ansorg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ansorg more than expected).

Fields of papers citing papers by R. Ansorg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ansorg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ansorg. The network helps show where R. Ansorg may publish in the future.

Co-authorship network of co-authors of R. Ansorg

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ansorg. A scholar is included among the top collaborators of R. Ansorg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ansorg. R. Ansorg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ansorg, R., et al.. (2002). Influence of Mucin on the Activity of the Antiseptic Lavasept<sup>®</sup> against <i>Staphylococcus aureus</i>. Chemotherapy. 48(3). 129–133. 12 indexed citations
2.
Ansorg, R., et al.. (2001). Isolation and Antimicrobial Susceptibility Testing of Fecal Strains of the Archaeon <i>Methanobrevibacter smithii</i>. Chemotherapy. 47(3). 177–183. 15 indexed citations
3.
Ansorg, R. & Ernst N. Schmid. (1998). Adhesion of Helicobacter pylori to yeast cells. Zentralblatt für Bakteriologie. 288(4). 501–508. 9 indexed citations
4.
Müller, Karl‐Dieter, et al.. (1998). Characterization of the periodontal microflora by the fatty acid profile of the broth-grown microbial population. Zentralblatt für Bakteriologie. 288(4). 441–449. 1 indexed citations
5.
Recklinghausen, G. von, et al.. (1998). Haemolytic activity of Helicobacter pylori against human and animal erythrocytes. Zentralblatt für Bakteriologie. 288(2). 207–215. 1 indexed citations
6.
Ansorg, R., et al.. (1997). Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses. 40(9-10). 353–357. 117 indexed citations
7.
Fabry, Werner, E. N. Schmid, & R. Ansorg. (1996). Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium avium complex. Journal of Medical Microbiology. 44(3). 227–230. 10 indexed citations
8.
Ansorg, R., et al.. (1996). Association between Incidence of Aspergillus Antigenemia and Exposure to Construction Works at a Hospital Site. Zentralblatt für Bakteriologie. 284(2-3). 146–152. 3 indexed citations
9.
Fabry, Werner, P. O. Okemo, & R. Ansorg. (1996). Activity of East African Medicinal Plants against <i>Helicobacter pylori</i>. Chemotherapy. 42(5). 315–317. 34 indexed citations
10.
Ansorg, R., et al.. (1995). Cat Owners' Risk of Acquiring a Helicobacter pylori iInfection. Zentralblatt für Bakteriologie. 283(1). 122–126. 18 indexed citations
11.
Rath, Peter‐Michael, et al.. (1995). Imipenem Inhibits in vitro Activity of Amphotericin B Directed Against Aspergillus Fumigatus. Zentralblatt für Bakteriologie. 283(1). 69–78. 2 indexed citations
12.
Ansorg, R., et al.. (1994). Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients. European Journal of Clinical Microbiology & Infectious Diseases. 13(7). 582–589. 44 indexed citations
13.
Hoyme, Udo B., R. Ansorg, G. von Recklinghausen, & A. E. Schindler. (1993). Chinolone in der Therapie der unkoplizierten Salpingitis: Ofloxacin/Metronidazol vs. Gentamicin/Clindamicin. Archives of Gynecology and Obstetrics. 254(1-4). 607–608. 3 indexed citations
14.
Ansorg, R., et al.. (1993). Cell-associated haemolytic activity ofHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases. 12(2). 98–104. 11 indexed citations
15.
Quabeck, K., et al.. (1992). Prophylaxis and treatment of fungal infections with fluconazole in bone marrow transplant patients. Mycoses. 35(9-10). 221–224. 5 indexed citations
16.
Müller, K, et al.. (1991). Flocculation of Venereal Disease Research Laboratory reagent byHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases. 10(9). 768–770. 3 indexed citations
17.
Ansorg, R., et al.. (1990). Inhibitory and Bactericidal Activity of Cefpirome and Cefotaxime against Blood Culture Isolates. Chemotherapy. 36(1). 24–28. 2 indexed citations
18.
Behrens‐Baumann, W. & R. Ansorg. (1985). Mezlocillin Concentrations in Human Aqueous Humour after Intravenous and Subconjunctival Administration. Chemotherapy. 31(3). 169–172. 3 indexed citations
19.
Ansorg, R., et al.. (1978). [Studies on the antimicrobial effect of natural and synthetic humic acids (author's transl)].. PubMed. 28(12). 2195–8. 11 indexed citations
20.
Ansorg, R., et al.. (1977). Binding of antibiotics by dialysis membranes and its clinical relevance.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14. 607–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026